Prof Bart De Strooper, UK DRI Director, has today been elected to the U.S. National Academy of Medicine (NAM), for his work in understanding the mechanisms of Alzheimer’s disease, ‘in an unrelenting search for therapeutic targets that can help patients’.
He is one of only 10 international researchers elected to the Academy this year, which recognises individuals who have demonstrated outstanding professional achievement and commitment to service.
New members are elected by current members through a process that recognises individuals who have made major contributions to the advancement of the medical sciences, health care, and public health. The newly elected members bring NAM’s total membership to more than 2,200, including 190 international members.